Displaying 1 - 12 of 14
Metabolism, Alcohol & Toxicity

Novo Nordisk: Personalised management of MASH (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Updates on the essence of MASH (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD's impact on metabolic health and quality of life – new evidence (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence (Complete Sess...

Webcasts
View
Metabolism, Alcohol & Toxicity

MASLD – current treatment  strategies  - from metabolic indices to patient reported outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Focusing on metabolic risk of MASLD. EXCEL study design and major outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and Closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Kickoff: The importance of early screening

Webcasts
View
Metabolism, Alcohol & Toxicity

Understanding burden of  MASLD: The Importance  on Quality of Life

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel discussion

Webcasts
View
Displaying 1 - 12 of 14